NDC 0615-8403 – Benzonatate
Benzonatate 100 mg/1 · Capsule · Oral
Product NDC0615-8403
Product details
- Brand name
- Benzonatate
- Generic name
- Benzonatate
- Labeler
- NCS HealthCare of KY, LLC dba Vangard Labs
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA091133
- Marketed since
- December 10, 2016
- Marketing end
- October 31, 2026
- Pharmacologic class
- Non-narcotic Antitussive
Active ingredients
- Benzonatate 100 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0615-8403-05 | 15 CAPSULE in 1 BLISTER PACK (0615-8403-05) | Jul 3, 2024 |
| 0615-8403-21 | 21 CAPSULE in 1 BLISTER PACK (0615-8403-21) | Feb 12, 2024 |
| 0615-8403-39 | 30 CAPSULE in 1 BLISTER PACK (0615-8403-39) | Oct 6, 2021 |
Other Benzonatate products
- 50090-6294 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-4968 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-6387 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5409 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-4969 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-5986 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 50090-6080 Benzonatate 200 mg/1 · Capsule · A-S Medication Solutions
- 50090-6850 Benzonatate 100 mg/1 · Capsule · A-S Medication Solutions
- 68084-214 Benzonatate 100 mg/1 · Capsule · American Health Packaging
- 87519-111 Benzonatate 150 mg/1 · Capsule · Anvi Pharmaceuticals Inc
- 71610-692 Benzonatate 100 mg/1 · Capsule · Aphena Pharma Solutions - Tennessee, LLC
- 67877-575 Benzonatate 200 mg/1 · Capsule · Ascend Laboratories, LLC